Skip to main content
Clinical Trials/NCT00013390
NCT00013390
Completed
Phase 2

Evaluation of Treatment Methods for Clinically Significant Tinnitus

US Department of Veterans Affairs1 site in 1 country200 target enrollmentOctober 1999
ConditionsTinnitus

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Tinnitus
Sponsor
US Department of Veterans Affairs
Enrollment
200
Locations
1
Primary Endpoint
Tinnitus Severity Index
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The investigators propose to evaluate two different approaches to the alleviation of tinnitus symptoms by comparing changes from baseline performance on the Tinnitus Severity Index. They propose to provide an unbiased evaluation of competing methodologies. The design is one in which pairs of prospective subjects are randomly assigned to one of two treatment groups. Changes in group performance will be compared for selected measures.

Registry
clinicaltrials.gov
Start Date
October 1999
End Date
September 2002
Last Updated
14 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with significant tinnitus

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Tinnitus Severity Index

Time Frame: Baseline, 3 mo., 6 mo., 12 mo., 18 mo.

A well-developed scale currently in use at the Oregon Tinnitus Clinic.

Study Sites (1)

Loading locations...

Similar Trials